In rat models of pre-eclampsia and chorioamnionitis, treatment with an anti-Flt-1 mAb improved infant lung structure and function, including increased vascular density and alveolarization, and prolonged neonatal survival.59 Here, FLT1 is linked to chorioamnionitis.